Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/19/21 16:05 | 8/17/21 | ONVO | Health | BioPrd | Biological Products, (No Diag | Cohen Douglas Jay | CA | D | P | 72 | 6.73 | 0 | 11 | 860 | 12 | M | |||||||||||||||
12/4/17 09:00 | 11/22/17 | ONVO | Health | BioPrd | Biological Products, (No Diag | Murphy Keith | CA | H | Former a | P.m | 501 | 1.49 | 0 | 336 | 6 | 6,374 | D | ||||||||||||||
8/13/15 20:12 | 8/13/15 | ONVO | Health | BioPrd | Biological Products, (No Diag | Glover James T | CA | D | P | 28 | 2.80 | 5 | 10 | New | 10 | D | -51 | -66 | -55 | -39 | -26 | -25 | -19 | -6 | -4 | -13 | 0 | 17 | -29 | ||
8/13/15 20:10 | 8/12/15 | ONVO | Health | BioPrd | Biological Products, (No Diag | Murphy Keith | CA | DO | CB,CEO,P | P | 51 | 2.56 | 5 | 20 | 0 | 5,944 | D | -51 | -66 | -55 | -39 | -26 | -25 | -19 | -6 | -4 | -13 | 0 | 17 | -29 | |
6/5/12 20:26 | 3/16/12 | ONVO | Health | BioPrd | Biological Products, (No Diag | Michaels Barry D | CA | O | CFO | P.ad | 10 | 1.00 | 0 | 10 | New | 10 | D | 208 | 148 | 85 | 58 | 40 | -12 | -2 | -36 | -62 | -63 | -29 | |||
3/20/12 18:14 | 3/16/12 | ONVO | Health | BioPrd | Biological Products, (No Diag | Michaels Barry D | CA | O | CFO | P.d | 10 | 1.00 | 0 | 10 | New | 10 | D | 43 | 33 | 2 | -3 | 8 | -3 | 306 | -15 | 63 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |